| Prior to producing Alomac, a human clinical trial was performed testing Aloe macroclada pills made by a traditional healer in Madagascar. The positive results were published: (https://www.walshmedicalmedia.com/open-access/aloe-macroclada-from-madagascar-triggers-transient-bone-marrow-stem-cell-mobilization-2157-7633-1000287.pdf) The amount of Aloe macroclada gel in the healer’s pills used in this first trial was estimated to be between 70-100mg. A second clinical trial was performed testing the dried inner leaf gel of Aloe macroclada at 250mg and 750mg. Both results were similarly positive, indicating the lowest effective dosage was at or below 250mg. The data from this trial is being prepared for publication. |
A second clinical trial was performed testing the dried inner leaf gel of Aloe macroclada at 250mg and 750mg. Both results were similarly positive, indicating the lowest effective dosage was at or below 250mg. The data from this trial is being prepared for publication.
.
A third, 6-month, clinical trial was performed using Aloe macroclada powder and a retail product containing powdered Aloe macroclada, Stemtech International’s product “StemEnhance3”. Unfortunately, Stemtech declared bankruptcy and the trial was terminated half way through (Stemtech was in legal trouble for having violated multiple trademarks and patents, including use of “StemEnhance3” – nothing to do with the product.) The data from this trial has yet to be published.
It is estimated that the first pills tested (made by traditional healer) had 70-100mg of the dry equivalent Aloe macroclada gel in 3 pills, the healer’s recommended dose. At this time, the recommended minimum dosage is 70-100mg, 3 times per day. Additional studies are needed to better understand the lowest optimal effective dose.
Increase in CD34+ stem cells following Aloe macroclada consumpti